Keywords: لوسمی حادمیولوز; Fusarium; Fungal; Gingival; Acute myelogenous leukemia; Neutropenia;
مقالات ISI لوسمی حادمیولوز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی حادمیولوز; childhood ptosis; acute myelogenous leukemia; chloroma; myeloid sarcoma; granulocytic sarcoma; myeloblastoma; orbital mass;
Keywords: لوسمی حادمیولوز; Acute leukemia; Acute myelogenous leukemia; Acute lymphoblastic leukemia; Emergency providers;
Keywords: لوسمی حادمیولوز; HD; Healthy donors; ALL; acute lymphocytic leukemia; AML; acute myelogenous leukemia; CE; cholesteryl esters; Lipids; Leukemia; Cholesterol; Metabolism; LDL-C; HDL-C;
Keywords: لوسمی حادمیولوز; Donor natural killer (NK) cell infusion; HLA-haploidentical hematopoietic cell transplantation; Acute myelogenous leukemia;
Keywords: لوسمی حادمیولوز; Myeloid sarcoma; Spinal cord compression; AML; Acute myelogenous leukemia; MRI; Magnetic resonance imaging;
Keywords: لوسمی حادمیولوز; Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: لوسمی حادمیولوز; Acute Myelogenous Leukemia; Autologous transplant; High-dose chemotherapy; Pharmacokinetics; Phase I Clinical Trial
Keywords: لوسمی حادمیولوز; ALL; acute lymphoblastic leukemia; AML; acute myelogenous leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; HL; Hodgkin lymphoma; HR; hazard ratio; IOM; Institute of Medicine; ICU; intensive care unit; MM; multiple myeloma; N
Keywords: لوسمی حادمیولوز; Clostridium difficile infection; Acute myelogenous leukemia; Allogeneic stem cell transplantation; Carbapenem
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Myelodysplastic syndrome; Reduced intensity; Transplantatiom; Alemtuzumab
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Adverse risk; Chromosomal aberration; Mosaicism; Monosomal karyotype
Keywords: لوسمی حادمیولوز; Acute leukemia; Acute myelogenous leukemia; Acute lymphoblastic leukemia; Emergency providers;
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Doxorubicin; Vectorization; Chemotherapy; Folate receptor;
Keywords: لوسمی حادمیولوز; AML; acute myelogenous leukemia; BD; 1,3-butadiene; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; EU; European Union; DMDTC; dimethyldithiocarbamate; HIT; high-intensity task; mle; maximum likelihood estimate; MoA; mode of action;
Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis
Keywords: لوسمی حادمیولوز; PTL; parthenolide; AML; acute myelogenous leukemia; CSCs; cancer stem cells; DMAPT; dimethylamino-parthenolide; PTDH; phosphite dehydrogenase; NADPH; nicotinamide adenine dinucleotide phosphate (reduced); IPTG; β-d-1-thiogalactopyranoside; δ-ALA; δ-ami
NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells
Keywords: لوسمی حادمیولوز; NDPK; nucleoside diphosphate kinase; ATRA; all-trans retinoic acid; EA; ellagic acid; AML; acute myelogenous leukemia; LPA; lysophosphatidic acid; EDG2/lpal; endothelial differentiation gene 2/LPA receptor 1; BC; breast cancer; NM23; EDG2/lpa1; ATRA; Myel
Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT
Keywords: لوسمی حادمیولوز; T cell exhaustion; Acute myelogenous leukemia; Relapse; Donor lymphocyte infusion; Allogeneic hematopoietic stem cell transplantation; Antileukemia response;
PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions
Keywords: لوسمی حادمیولوز; Pura (Pur-alpha); Purb; Pur-beta; Purg; Pur-gamma-A and Pur-gamma-B; AIDS; Myelodysplastic syndrome; Acute myelogenous leukemia; AML; Progressive multifocal leukoencephalopathy; PML; Polyomavirus JC; JCV; Fragile X syndrome; FXS; FMR1; Amyotrophic lateral
Deubiquitylating enzymes as cancer stem cell therapeutics
Keywords: لوسمی حادمیولوز; Protein-IPSC; protein-induced pluripotent stem cells; CSCs; cancer stem cells; DUBs; deubiquitylating enzymes; ESCs; embryonic stem cells; PTMs; post-translational modifications; AML; acute myelogenous leukemia; USP/UBP; ubiquitin-specific processing prot
Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016
Keywords: لوسمی حادمیولوز; BMFS; bone marrow failure syndromes; HSC; hematopoietic stem cell; BM; bone marrow; AML; acute myelogenous leukemia; MDS; myelodysplastic syndromes; LSC; leukemia stem cell; CHIP; clonal hematopoiesis of indeterminate potential; MDSCs; myeloid derived sup
Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality
Keywords: لوسمی حادمیولوز; inv (3); Karyotype; Cytogenetics; Acute myelogenous leukemia; Allogeneic hematopoietic cell transplantation;
RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Chronic myelogenous leukemia; FLT3; RNA binding proteins; Post-transcriptional regulation;
Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies
Keywords: لوسمی حادمیولوز; AML; acute myelogenous leukemia; ANC; absolute neutrophil counts; CCI; Charlson comorbidity index; CI; confidence interval; CIFN; chemotherapy-induced febrile neutropenia; CR; complete remission; G-CSF; granulocyte colony-stimulating factor; NCCN; Nationa
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential
Keywords: لوسمی حادمیولوز; ADME; absorption, distribution, metabolism, and excretion; AML; acute myelogenous leukemia; AUC; area under the blood concentration time curve; b.i.d.; twice a day; CDK; Cyclin-dependent kinase; CLtotal; clearance; Cmax; maximum drug concentration; CRC; c
Reviving the guardian of the genome: Small molecule activators of p53
Keywords: لوسمی حادمیولوز; AML; acute myelogenous leukemia; CML; chronic myelogenous leukemia; INZ; inauhzin; p53; Small molecules; MDM2; MDMX; Drug discovery; Inauhzin;
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Keywords: لوسمی حادمیولوز; AAH; atypical adenomatous hyperplasia; AK; actinic keratosis; AML; acute myelogenous leukemia; AMM; asymptomatic multiple myeloma; APC; antigen presenting cell; B-ALL; B cell acute lymphocytic leukemia; B-CLL; B cell chronic lymphocytic leukemia; BD; Bowe
Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes
Keywords: لوسمی حادمیولوز; Biosimilar; Granulocyte colony-stimulating factor (G-CSF); Allogeneic hematopoietic stem transplantation; Normal donors; Siblings; Myelodysplastic syndromes; Acute myelogenous leukemia;
How important is NK alloreactivity and KIR in allogeneic transplantation?
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Allogeneic hematopoietic cell transplantation; Allo HCT; Alloreactivity; AML; Graft versus host disease; GVHD; Graft versus leukemia; GVL; Killer Ig-like receptors; KIR; Natural killer; NK;
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting
Keywords: لوسمی حادمیولوز; (JAK2); Janus kinase 2; (MPN); myeloproliferative neoplasms; (PV); polycythemia vera; (ET); essential thrombocythemia; (PMF); Primary myelofibrosis; (CALR); calreticulin; (HRM); high resolution melting; (CML); chronic myelogenous leukemia; (Hb); hemoglobi
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD-Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Allogeneic hematopoietic stem cell transplantation; FLT3; FLT3-ITD; Tyrosine kinase inhibitor;
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Keywords: لوسمی حادمیولوز; Human double minute 2 inhibitor; MK-8242; Acute myelogenous leukemia; p53; Phase I;
Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged â¥70 Years
Keywords: لوسمی حادمیولوز; Umbilical cord blood transplantation; Acute myelogenous leukemia; Myelodysplastic syndrome; Old age;
FLT3 Inhibitors for Treating Acute Myeloid Leukemia
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Fms-like tyrosine kinase 3; Internal tandem duplication; Sorafenib; Tyrosine kinase inhibitors;
Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors
Keywords: لوسمی حادمیولوز; 4-MH; 4-methylhistamine; AML; acute myelogenous leukemia; CML; chronic myelogenous leukemia; cAMP; cyclic adenosine monophosphate; CRE; cAMP response element; EGFR; epidermal growth factor receptor; ER; estrogen receptor alpha; FSK; Forskolin; GPCR; G-pro
Gleditsia species: An ethnomedical, phytochemical and pharmacological review
Keywords: لوسمی حادمیولوز; AFGS; the ethanol extract from the anomalous fruits of Gleditsia sinensis Lam.; ALI; acute lung injury; AML; acute myelogenous leukemia; AP-1; activator protein-1; ARDS; acute respiratory distress syndrome; bFGF; basic fibroblast growth factor; CDK; cycli
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Keywords: لوسمی حادمیولوز; ALL; acute lymphocytic leukemia; AML; acute myelogenous leukemia; AS; activation segment; CS or C-spine; catalytic spine; CL; catalytic loop; HΦ or Φ; hydrophobic; IFN; interferon; IL; interleukin; JAK1/2; Janus kinases 1 and 2; MW; molecular weight; NS
The Outcome of Allogeneic Hematopoietic Cell Transplantation for Children with FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication–Positive Acute Myelogenous Leukemia
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Children; FLT3 internal tandem duplication (FLT3/ITD)
IDH1, lipid metabolism and cancer: Shedding new light on old ideas
Keywords: لوسمی حادمیولوز; IDH1; isocitrate dehydrogenase 1; AML; acute myelogenous leukemia; PC; phosphatidylcholine; PE; phosphatidylethanolamine; PS; phosphatidylserine; PI; phosphatidylinositol; 2-HG; 2 hydroxyglutarate; RCDP; rhizomelic chondrodysplasia punctata; NADP; nicotin
A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Clinical study; JAK2V617 mutation; Janus kinase inhibitor; Myelofibrosis; Ruxolitinib
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia-Impact on enzyme activity and response to cytotoxics
Keywords: لوسمی حادمیولوز; DMT; N-desmethyltamoxifen; AC; acid ceramidase; AML; acute myelogenous leukemia; SphK1; sphingosine kinase 1; S1-P; sphingosine 1-phosphate; GC; glucosylceramide; 4-HPR; fenretinide; GCS; glucosylceramide synthase; P-gp; P-glycoprotein; ATCC; American Typ
Single-Unit Cord Blood Transplantation after Granulocyte Colony-Stimulating Factor–Combined Myeloablative Conditioning for Myeloid Malignancies Not in Remission
Keywords: لوسمی حادمیولوز; Cord blood transplantation; Granulocyte colony-stimulating factor; Acute myelogenous leukemia; Myelodysplastic syndrome; not in remission
Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1
Keywords: لوسمی حادمیولوز; HIV; latency; eradication; reservoir; cure; stem cell transplantation; antiretroviral therapy; AML; Acute myelogenous leukemia; ART; Combination antiretroviral therapy; HCV; Hepatitis C virus; HSCT; Hematopoietic stem cell transplantation; LRA; Latency-re
Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Keywords: لوسمی حادمیولوز; Acute leukemia; Acute lymphoblastic leukemia; Acute myelogenous leukemia; Allogeneic hematopoietic stem cell transplantation; Extramedullary relapse
Regular ArticleThrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: A retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort
Keywords: لوسمی حادمیولوز; APL; acute promyelocytic leukemia; AML; acute myelogenous leukemia; PML; promyelocytic leukemia; RARα; retinoic acid receptor-α; DIC; disseminated intravascular coagulation; ATRA; all-trans retinoic acid; ED; early death; TM; thrombomodulin; JALSG; Japa
Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; CCAAT/enhancer binding protein; CEBPA; CEBPD; CEBPE; CEBPZ(DDIT3); DNA methylation; Gene expression;
The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Guaianolide-type sesquiterpene lactones; Micheliolide; Dehydrocostus lactone; Synthesis
Acute myelogenous leukemia stem cells: From Bench to Bedside
Keywords: لوسمی حادمیولوز; AML; Leukemia; LSC; Leukemia stem cell; Acute myelogenous leukemia; Therapies; Chemoresistance
Unrelated Donor Allogeneic Transplantation after Failure of Autologous Transplantation for Acute Myelogenous Leukemia: A Study from the Center for International Blood and Marrow Transplantation Research
Keywords: لوسمی حادمیولوز; Acute myelogenous leukemia; Unrelated donor; Transplantation; Allogeneic; Autologous
Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden
Keywords: لوسمی حادمیولوز; Refractory/relapsed; Acute myelogenous leukemia; Allogeneic peripheral blood stem cell transplantation; Graft-versus-leukemia